BioCardia, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
BCDA Nasdaq 2836 www.biocardia.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for BioCardia, Inc.

BioCardia to Host Q2 2026 Financial Results and Corporate Update Conference Call on August 12, 2026 - Aug 5th, 2026 1:16 pm
Congestive Heart Failure Market to Register Immense Growth at a CAGR of 8% During the Forecast Period (2026-2036) | DelveInsight - Jul 28th, 2026 8:32 am
New Strong Sell Stocks for July 14th - Jul 14th, 2026 5:16 am
BioCardia Letter to Stockholders on 2026 Priorities and Strategic Opportunities - Jun 18th, 2026 6:00 am
BioCardia Announces $4.4 Million Financing - Jun 8th, 2026 6:00 am
Sector Update: Healthcare Stocks Higher Late Afternoon - Jun 5th, 2026 1:49 pm
Sector Update: Healthcare Stocks Gain Friday Afternoon - Jun 5th, 2026 11:50 am
Top Midday Gainers - Jun 5th, 2026 11:29 am
Why Did BCDA Stock Surge More Than 50% Today? - Jun 5th, 2026 10:25 am
BioCardia Shares Rally After FDA Supports Regulatory Path for Heart Failure Therapy (BCDA) - Jun 5th, 2026 8:31 am
FDA Confirms CardiAMP HF II May Support Premarket Approval of CardiAMP Cell Therapy for Ischemic HFrEF - Jun 5th, 2026 6:00 am
BioCardia Announces Japan PMDA Record Of Advice Supports Regulatory Submission For Approval Of CardiAMP Cell Therapy For Ischemic Heart Failure - May 28th, 2026 6:00 am
BioCardia Announces CardiAMP Chronic Myocardial Ischemia Trial Results Presented at EuroPCR Showed Durable Improvements in Exercise Tolerance with Reduced Angina Frequency - May 21st, 2026 6:00 am
BioCardia to Participate in a Fireside Chat at the Alliance Global Partners (A.G.P) Healthcare Company Showcase - May 19th, 2026 6:00 am
BioCardia (BCDA) Q1 2026 Earnings Transcript - May 18th, 2026 7:00 am
BioCardia, Inc. Q1 2026 Earnings Call Summary - May 16th, 2026 6:30 am
BioCardia Inc (BCDA) Q1 2026 Earnings Call Highlights: Breakthroughs in Cardiac Therapy and ... - May 15th, 2026 11:00 pm
BioCardia Reports First Quarter 2026 Business Highlights and Financial Results - May 15th, 2026 6:00 am
BioCardia to Host Q1 2026 Financial Results and Corporate Update Conference Call on May 15, 2026 - May 11th, 2026 3:10 pm
BioCardia and FDA Align on Helix Transendocardial Delivery Catheter Clearance Pathways - May 8th, 2026 6:00 am